Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritis

MLA

Jonas Engesser, et al. “Immune Profiling-Based Targeting of Pathogenic T Cells with Ustekinumab in ANCA-Associated Glomerulonephritis.” Nature Communications, vol. 15, no. 1, Sept. 2024, pp. 1–12. EBSCOhost, https://doi.org/10.1038/s41467-024-52525-w.

APA

Jonas Engesser, Robin Khatri, Darius P. Schaub, Yu Zhao, Hans-Joachim Paust, Zeba Sultana, Nariaki Asada, Jan-Hendrik Riedel, Varshi Sivayoganathan, Anett Peters, Anna Kaffke, Saskia-Larissa Jauch-Speer, Thiago Goldbeck-Strieder, Victor G. Puelles, Ulrich O. Wenzel, Oliver M. Steinmetz, Elion Hoxha, Jan-Eric Turner, Hans-Willi Mittrücker, … Ulf Panzer. (2024). Immune profiling-based targeting of pathogenic T cells with ustekinumab in ANCA-associated glomerulonephritis. Nature Communications, 15(1), 1–12. https://doi.org/10.1038/s41467-024-52525-w

Chicago

Jonas Engesser, Robin Khatri, Darius P. Schaub, Yu Zhao, Hans-Joachim Paust, Zeba Sultana, Nariaki Asada, et al. 2024. “Immune Profiling-Based Targeting of Pathogenic T Cells with Ustekinumab in ANCA-Associated Glomerulonephritis.” Nature Communications 15 (1): 1–12. doi:10.1038/s41467-024-52525-w.